Leverkusen, Germany, 19 May 2014 -The management board of Biofrontera AG (Biofrontera) has resolved today, with the approval of the supervisory board, to apply to the Frankfurt Stock Exchange to list its shares in the "Prime Standard" segment. Currently, the shares of Biofrontera are listed in the regulated market segment "General Standard". The segment "Prime Standard" enacts additional transparency requirements for the benefit of shareholders.
At the same time, it was resolved to acquire an additional listing of the shares of Biofrontera on the Alternative Investment Market (AIM) segment of the London Stock Exchange, in order to facilitate better access to the international capital markets and to improve the trading liquidity of the shares. UK institutional investors have requested, in many cases, a listing on AIM as a precondition for an investment in Biofrontera.
The listing at the AIM is effected in cooperation with the investment firm FinnCap, London, which will also function as nominated advisor and broker in respect of trading on the London Stock Exchange.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611
Contact:
Biofrontera AG
Tel.: +49 (0214) 87 63 2 22, Fax.: +49 (0214) 87 63 290
E-mail: press@biofrontera.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biofrontera AG via GlobeNewswire
HUG#1786776